|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2640749 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11781571.2 |
| Date of filing the European patent application | 2011-11-14 | |
| (97) | Date of publication of the European application | 2013-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation | 2017-07-10 |
| (86) | Number | PCT/EP2011/070058 |
| Date | 2011-11-14 |
| (87) | Number | WO 2012/065950 |
| Date | 2012-05-24 |
| (30) | Number | Date | Country code |
| 413567 P | 2010-11-15 | US |
| (72) |
HEUSSER, Christoph, CH
RUSH, James, CH
VINCENT, Karen, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-CD40 antikūnų "tylintys" Fc variantai |
| SILENT FC VARIANTS OF ANTI-CD40 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-10-21 | 14 | 289.00 EUR |
| 2025-11-14 |